Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity

scientific article

Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.7554/ELIFE.11156
P3181OpenCitations bibliographic resource ID1189217
P932PMC publication ID4931907
P698PubMed publication ID27244239

P50authorEric VerdinQ37373521
Melanie OttQ42321952
Jordan L MeierQ42408758
John C NewmanQ97643499
Tadahiro ShimazuQ115138374
P2093author name stringLan Wang
Hyung W Lim
Ronen Marmorstein
Sebastian Schröder
Alexander W Sorum
Intelly S Lee
Jasna Maksimoska
Kotaro Shirakawa
Na Man
Stephen Nimer
P2860cites workDrugBank: a comprehensive resource for in silico drug discovery and explorationQ24188653
Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenaseQ24563699
The ancient drug salicylate directly activates AMP-activated protein kinaseQ24630758
Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysisQ24646764
DrugBank: a knowledgebase for drugs, drug actions and drug targetsQ24650300
CBP/p300-mediated acetylation of histone H3 on lysine 56Q24657910
Structure of the p300 Histone Acetyltransferase Bound to Acetyl-Coenzyme A and Its AnaloguesQ27683746
Chromatin modifications and their functionQ27861067
Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB.Q28118359
Duration of nuclear NF-kappaB action regulated by reversible acetylationQ28215080
Inhibition of tumor necrosis factor-induced p42/p44 mitogen-activated protein kinase activation by sodium salicylateQ28278215
Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylateQ28343291
Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substratesQ28609842
Inhibition of NF-kappa B by sodium salicylate and aspirinQ29614708
Andromeda: a peptide search engine integrated into the MaxQuant environmentQ29615816
Type 2 diabetes as an inflammatory diseaseQ29617184
The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-betaQ29617188
Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugsQ29617192
Chemoproteomic profiling of lysine acetyltransferases highlights an expanded landscape of catalytic acetylationQ34489555
Plant orthologs of p300/CBP: conservation of a core domain in metazoan p300/CBP acetyltransferase-related proteinsQ34578212
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trialQ35111527
The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylationQ35650662
Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation.Q36071867
Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition ofQ36657975
Amino acid conjugation: contribution to the metabolism and toxicity of xenobiotic carboxylic acidsQ36788394
A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose toleranceQ37101773
Histone acetyl transferases as emerging drug targets.Q37540911
Life and death of transcriptional co-activator p300.Q37897823
Salicylates inhibit lipopolysaccharide-induced transcriptional activation of the tissue factor gene in human monocytic cellsQ38288860
Salicylic acid fails to inhibit generation of thromboxane A2 activity in platelets after in vivo administration to the ratQ39182760
AMP-activated protein kinase suppresses endothelial cell inflammation through phosphorylation of transcriptional coactivator p300.Q39469473
An electrophoretic mobility shift assay for the identification and kinetic analysis of acetyl transferase inhibitorsQ39722811
24 Large-scale synthesis of coenzyme A estersQ41521643
NPR3 and NPR4 are receptors for the immune signal salicylic acid in plantsQ41831053
Selective inhibition of cyclooxygenase-1 and -2 using intact insect cell assaysQ42063204
Regulation of the p300 HAT domain via a novel activation loop.Q42458138
CBP/p300 histone acetyl-transferase activity is important for the G1/S transitionQ42801428
Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the 'second hit' hypothesisQ42808699
Regulation of activity of the transcription factor GATA-1 by acetylationQ42823439
Small molecule modulators of histone acetyltransferase p300.Q44353899
Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vectorQ45864375
In vitro drug interaction between diflunisal and indomethacin via glucuronidation in humans.Q51940716
Regulation of interaction of the acetyltransferase region of p300 and the DNA-binding domain of Sp1 on and through DNA binding.Q52171368
p300 is required for orderly G1/S transition in human cancer cells.Q52572534
Pharmacokinetics of diflunisal in patientsQ70150437
Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigrationQ71059480
Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugsQ74097807
Cell-type-specific activation of c-Jun N-terminal kinase by salicylatesQ74614681
P407language of work or nameEnglishQ1860
P921main subjectsalicylic acidQ193572
P577publication date2016-05-31
P1433published ineLifeQ2000008
P1476titleSalicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity
P478volume5

Reverse relations

cites work (P2860)
Q39147132A chemical probe toolbox for dissecting the cancer epigenome
Q90069095A genome-wide screen for human salicylic acid (SA)-binding proteins reveals targets through which SA may influence development of various diseases
Q64254374A novel mechanism for the anticancer activity of aspirin and salicylates
Q51766671Aspirin Recapitulates Features of Caloric Restriction.
Q92547110Aspirin Reshapes Acetylomes in Inflammatory and Cancer Cells via CoA-Dependent and CoA-Independent Pathways
Q64110669Aspirin impairs acetyl-coenzyme A metabolism in redox-compromised yeast cells
Q41072898Aspirin increases metabolism through germline signalling to extend the lifespan of Caenorhabditis elegans
Q39180002Aspirin increases mitochondrial fatty acid oxidation.
Q38728228Aspirin therapy reduces the ability of platelets to promote colon and pancreatic cancer cell proliferation: Implications for the oncoprotein c-MYC.
Q90598267Choline supported poly(ionic liquid) graft copolymers as novel delivery systems of anionic pharmaceuticals for anti-inflammatory and anti-coagulant therapy
Q59132138Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells
Q48117508Defining Metabolic and Nonmetabolic Regulation of Histone Acetylation by NSAID Chemotypes.
Q41444894Diflunisal inhibits prestin by chloride-dependent mechanism
Q42513461Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth
Q90643583Lifespan-increasing drug nordihydroguaiaretic acid inhibits p300 and activates autophagy
Q48098684Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics.
Q58799330Recent advances in the understanding and treatment of acute myeloid leukemia
Q39113288Salsalate treatment following traumatic brain injury reduces inflammation and promotes a neuroprotective and neurogenic transcriptional response with concomitant functional recovery.
Q90999129TAF1 plays a critical role in AML1-ETO driven leukemogenesis
Q92997886The Cytotoxicity and Synergistic Potential of Aspirin and Aspirin Analogues Towards Oesophageal and Colorectal Cancer
Q38697027The aspirin metabolite salicylate inhibits lysine acetyltransferases and MUC1 induced epithelial to mesenchymal transition

Search more.